Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05345405 · ClinicalTrials.gov registry record · NA
Clinical Trial of a Supporter-Targeted Intervention to Improve Outcomes in Recent Sexual Assault Survivors
A NA study of Stress and Stress Disorders, Post-Traumatic, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT05345405: Completed NA study of Stress and Stress Disorders, Post-Traumatic, sponsored by University of Washington.
NCT05345405 is a NA study of Stress and Stress Disorders, Post-Traumatic that has completed, run by University of Washington. The registered enrollment target is 128 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05345405, a NA study of Stress and Stress Disorders, Post-Traumatic, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
Communication and Recovery Enhancement (CARE) is a 2-session early intervention for survivors of recent sexual assault and their supporters that aims to improve supporters' ability to respond effectively. The goal of this pilot trial is to understand the acceptability and preliminary efficacy of two versions of CARE: a version in which survivors and supporters attend both sessions together (dyadic CARE) and a version in which supporters attend sessions alone (supporter-only CARE). Survivors aged 14+ with elevated posttraumatic stress symptoms will enroll with a supporter of their choosing. Dyads will be randomized to dyadic CARE, supporter-only CARE, or waitlist control, and will complete self-report assessments at baseline, post-session-1, and follow-ups (1, 2, and 3 months post-baseline). Results will be used to inform future changes to CARE and determine whether a fully-powered randomized controlled trial is warranted.
Primary Outcome
Sum score on Client Satisfaction Scale, completed by survivor. Range: 8 to 32; higher scores indicate greater satisfaction
Conditions Studied
Interventions
- BEHAVIORAL Dyadic CARE
- BEHAVIORAL Supporter-Only CARE
Study Locations (1)
Washington
- University of Washington School of Medicine - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2024-07-04 |
| Phase | NA |
What the finished NCT05345405 record still lists
NCT05345405 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (84% lower).
The record links to 8 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Dyadic CARE is the first listed.
NCT05345405 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05345405 about?
NCT05345405 is a clinical study titled "Clinical Trial of a Supporter-Targeted Intervention to Improve Outcomes in Recent Sexual Assault Survivors". Communication and Recovery Enhancement (CARE) is a 2-session early intervention for survivors of recent sexual assault and their supporters that aims to improve supporters' ability to respond effectively. The goal of this pilot trial is to understand the acceptability and preliminary efficacy of two...
What is the current status of trial NCT05345405?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2022-05-18. Estimated completion is 2024-07-04.
What conditions does trial NCT05345405 study?
This clinical trial studies the following conditions: Stress, Stress Disorders, Post-Traumatic, Sexual Assault, Sexual Violence, Help-Seeking Behavior.
What interventions are being tested in trial NCT05345405?
The interventions under investigation include: Dyadic CARE (BEHAVIORAL), Supporter-Only CARE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05345405?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05345405 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05345405's enrollment target sits among peer trials
128 50th of 152 higher than 103 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI